Nomad Power Solutions, Inc.
NMAD Nasdaq Pharmaceutical Preparations Financials FY2016โFY2025
Last close ยท Oct 23, 2026
$3.81
5.8%What Nomad Power Solutions, Inc. does
No business description yet.
- Legal name
- NOMAD POWER SOLUTIONS, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K ยท Mar 31, 2026
- Accession ยท CIK
- 0001493152-26-014052
0001335105
Revenue and margins
Nomad Power Solutions, Inc. had โ of revenue in fiscal 2025.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ in fiscal 2025, โ of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Nomad Power Solutions, Inc. returned โ to shareholders in fiscal 2025. The diluted share count rose 115.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Nomad Power Solutions, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.8M | $5.4M | $4.2M | $1.0M | $5.1M |
| Interest coverage | โ908.2x | โ709.2x | โ314.2x | โ212.7x | โ555.2x |
| Current ratio | 16.8x | 14.1x | 13.7x | 3.6x | 3.9x |
| Quick ratio | 16.8x | 14.1x | 13.7x | 3.6x | 3.9x |
| Total assets | $5.1M | $5.6M | $4.3M | $1.1M | $12.7M |
| Total liabilities | $0.3M | $0.4M | $0.3M | $0.3M | $1.8M |
| Shareholders' equity | $4.8M | $5.2M | $4.0M | $0.8M | $9.7M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 6 | โ / 6 | โ / 6 | โ / 6 | โ / 6 | โ / 6 | โ / 6 | โ / 6 | โ / 6 |
| Accruals ratio | โ105.5% | โ44.0% | โ21.8% | โ117.4% | โ28.7% | โ50.1% | โ31.9% | โ16.1% | โ15.5% | โ43.3% |
| Altman Z'' | โ184.58 | โ54.97 | 4.94 | โ22.59 | 7.47 | โ9.83 | โ13.27 | โ25.17 | โ161.67 | โ9.86 |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Research and development | $0.9M | $0.5M | $0.0M | $0.8M | $1.2M | $1.7M | $1.3M | $0.9M | $0.7M | $0.3M |
| Operating income | โ$2.1M | โ$1.8M | โ$2.1M | โ$2.5M | โ$3.3M | โ$6.7M | โ$6.3M | โ$5.1M | โ$3.6M | โ$5.1M |
| Interest expense | โ | โ | โ | โ | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Income tax | โ | โ | โ | โ | โ | โ | โ | โ | โ | $0.0M |
| Net income | โ$2.1M | โ$1.8M | โ$2.1M | โ$2.4M | โ$3.3M | โ$6.7M | โ$6.3M | โ$5.1M | โ$3.6M | โ$6.1M |
| Net income to common | โ$2.1M | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Diluted EPS | โ$0.04 | โ$0.03 | โ$0.04 | โ$0.22 | โ$0.29 | โ$0.50 | โ$3.99 | โ$2.66 | โ$1.59 | โ$1.26 |
| Diluted shares | 0.05B | 0.06B | 0.06B | 0.01B | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | โ$1.7M | โ$1.4M | โ$1.5M | $1.7M | โ$2.1M | โ$4.1M | โ$4.6M | โ$4.3M | โ$3.2M | โ$3.1M |
| Stock-based compensation | $0.3M | $0.1M | $0.8M | $0.7M | $1.3M | $2.6M | $1.5M | $0.8M | $0.4M | $1.4M |
| Acquisitions | โ | โ | โ | โ | โ | โ | โ | โ | โ | $6.6M |
| Share buybacks | โ | โ | $0.0M | โ | โ | โ | โ | โ | โ | โ |
| Dividends and buybacks | โ | โ | $0.0M | โ | โ | โ | โ | โ | โ | โ |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.2M | $1.3M | $4.3M | $2.6M | $5.1M | $4.8M | $5.4M | $4.2M | $1.0M | $5.1M |
| Current assets | $0.4M | $1.4M | $4.3M | $2.7M | $5.2M | $5.1M | $5.6M | $4.3M | $1.1M | $5.2M |
| Current liabilities | $0.2M | $0.4M | $0.2M | $0.2M | $0.2M | $0.3M | $0.4M | $0.3M | $0.3M | $1.3M |
| Property and equipment, net | โ | โ | โ | โ | โ | โ | โ | โ | โ | $6.6M |
| Total assets | $0.4M | $1.4M | $4.3M | $2.7M | $5.2M | $5.1M | $5.6M | $4.3M | $1.1M | $12.7M |
| Total liabilities | $0.2M | $0.4M | $0.2M | $0.2M | $0.2M | $0.3M | $0.4M | $0.3M | $0.3M | $1.8M |
| Preferred stock | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | โ |
| Shareholders' equity | $0.2M | $1.0M | $4.1M | $2.4M | $5.0M | $4.8M | $5.2M | $4.0M | $0.8M | $9.7M |
| Returns | ||||||||||
| Return on capital employed | โ994.4% | โ181.9% | โ51.8% | โ102.3% | โ65.2% | โ140.3% | โ122.2% | โ127.4% | โ431.9% | โ44.8% |
| Return on equity | โ993.8% | โ299.0% | โ83.3% | โ74.4% | โ87.7% | โ137.3% | โ126.8% | โ111.1% | โ148.7% | โ115.9% |
| Return on assets | โ492.5% | โ200.8% | โ74.8% | โ69.6% | โ82.7% | โ130.4% | โ118.5% | โ103.1% | โ131.5% | โ87.6% |
| Return on tangible equity | โ993.8% | โ181.7% | โ51.7% | โ100.3% | โ65.1% | โ140.5% | โ122.2% | โ127.3% | โ433.5% | โ62.9% |
| Growth | ||||||||||
| Share count change | โ | 16.6% | 5.3% | โ81.0% | 0.9% | 19.5% | โ88.3% | 21.1% | 17.4% | 115.2% |
| Financial health | ||||||||||
| Interest coverage | โ | โ | โ | โ | โ882.8x | โ908.2x | โ709.2x | โ314.2x | โ212.7x | โ555.2x |
| Current ratio | 2.0x | 3.7x | 20.6x | 11.2x | 24.2x | 16.8x | 14.1x | 13.7x | 3.6x | 3.9x |
| Quick ratio | 2.0x | 3.7x | 20.6x | 11.2x | 24.2x | 16.8x | 14.1x | 13.7x | 3.6x | 3.9x |
| Quality scores | ||||||||||
| Altman Z'' | โ184.6 | โ55.0 | 4.9 | โ22.6 | 7.5 | โ9.8 | โ13.3 | โ25.2 | โ161.7 | โ9.9 |
| Accruals ratio | โ105.5% | โ44.0% | โ21.8% | โ117.4% | โ28.7% | โ50.1% | โ31.9% | โ16.1% | โ15.5% | โ43.3% |
Source: SEC EDGAR XBRL filings (CIK 0001335105). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
